Arrowstreet Capital, Limited Partnership Haemonetics Corp Transaction History

Arrowstreet Capital, Limited Partnership

$121 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$81.24 - $97.37 $4.66 Million - $5.59 Million	-57,387 Reduced 34.26%	110,110 $9.11 Million
Q1 2024 May 15, 2024	BUY	$71.24 - $85.35 $675,355 - $809,118	9,480 Added 6.0%	167,497 $14.3 Million
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $6.22 Million - $7.15 Million	-77,187 Reduced 32.82%	158,017 $13.5 Million
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $36 Million - $40.8 Million	-435,981 Reduced 64.96%	235,204 $21.1 Million
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $819,475 - $906,754	10,137 Added 1.53%	671,185 $57.1 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $2.45 Million - $3.06 Million	33,730 Added 5.38%	661,048 $54.7 Million
Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $33.6 Million - $39.1 Million	454,459 Added 262.91%	627,318 $49.3 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $8.81 Million - $10.9 Million	139,181 Added 413.27%	172,859 $12.8 Million
Q2 2022 Aug 15, 2022	BUY	$49.27 - $66.08 $1.66 Million - $2.23 Million	33,678 New	33,678 $2.2 Million
Q2 2021 Aug 13, 2021	SELL	$51.81 - $118.56 $2.04 Million - $4.66 Million	-39,300 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$111.01 - $139.48 $4.1 Million - $5.16 Million	36,972 Added 1588.14%	39,300 $4.36 Million
Q4 2020 Feb 12, 2021	SELL	$88.75 - $119.95 $14.4 Million - $19.4 Million	-161,874 Reduced 98.58%	2,328 $276,000
Q3 2020 Nov 12, 2020	SELL	$75.65 - $93.58 $3.23 Million - $4 Million	-42,731 Reduced 20.65%	164,202 $14.3 Million
Q2 2020 Aug 12, 2020	BUY	$84.96 - $118.91 $17.6 Million - $24.6 Million	206,933 New	206,933 $18.5 Million
Q3 2019 Nov 14, 2019	SELL	$117.16 - $138.52 $2.09 Million - $2.48 Million	-17,873 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $549,864 - $809,527	-6,727 Reduced 27.35%	17,873 $2.15 Million
Q1 2019 May 15, 2019	BUY	$83.25 - $102.12 $2.05 Million - $2.51 Million	24,600 New	24,600 $2.15 Million
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $17 Million - $21.9 Million	-187,848 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $22.6 Million - $28.8 Million	-251,434 Reduced 57.24%	187,848 $21.5 Million
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $25.4 Million - $34 Million	355,412 Added 423.77%	439,282 $39.4 Million
Q1 2018 May 14, 2018	BUY	$60.72 - $74.41 $5.09 Million - $6.24 Million	83,870 New	83,870 $6.14 Million
Q4 2017 Feb 09, 2018	SELL	$44.96 - $58.99 $6.96 Million - $9.14 Million	-154,861 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$40.38 - $44.87 $6.25 Million - $6.95 Million	154,861	154,861 $6.95 Million

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$510 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$442 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$380 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$359 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$345 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.39B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account